1. 7th Framework Program 2007-2013 Achilleas D. Stalios
European Commission -DG Research-
Industrial Technologies Directorate -Materials-

2. Funding programmes Education - Lifelong Learning Programme
Research- FRAMEWORK PROGRAMMES
- Seventh Framework Programme for research and
development
Innovation
- Competitiveness and Innovation Programme
Structural and Cohesion Funds

3. R&D – European weaknessesUS
Japan
R&D intensity (% of GDP) (3)
1.97
2.59
3.12
Share of R&D financed by industry (%) (2)
55.9
63.1
73.9
Researchers per thousand labour force (FTE) (3)
5.5
9.0
9.7
Share of world scientific publications (%) (3)
38.3
31.1
9.6
Scientific publications per million population (3)
639
809
569
Share of world triadic patents (%) (1)
31.5
34.3
26.9
Triadic patents per million population (1)
30.5
53.1
92.6
High-tech exports as a share of total manufacturing exports (%) (3)
19.7
28.5
26.5
Share of world high-tech exports (%) (2)
16.7
20.0
10.6
Note: (1) 2000 data (2) 2002 data (3) 2003 data

5. Towards The 7th Framework Programme 2007-2013 (‘co-decision’)
Directorates Generals involved in Research and contributing to FP7-
Research
Information Society and Communication
Transport and Energy
Enterprise
Fishery

6. FP7 : What’s new? Main elements: Duration increased to seven years
New FP7
Main
elements:
Duration increased to seven years
Total budget of €50.5 billion=>63% increase
Frontier research (~ €1.1 billion per year)
New structure:
Cooperation – Ideas – People – Capacities
Flexible funding schemes
Joint Technology initiatives
Simpler procedures
Outsourcing

7. FP7 2007 –2013 Specific Programmes
Cooperation – Collaborative research
Ideas – Frontier Research
People – Marie Curie Actions
Capacities – Research Capacity +
JRC (non-nuclear)
Cooperation- Collaborative Research
The largest one
JRC (nuclear)
Euratom

8. Total European Community budget for non-nuclear research:
FP7/ Budget
Ideas
7 460 €M
Cooperation €M
People
4 728 €M
Capacities
4 217 €M
Non-nuclear JRC
1 751 €M
Total European Community budget for non-nuclear research:
50.52 € billions

9. FP7/ Cooperation programme http://cordis.europa.eu/fp7/cooperation

10. FP7/ Cooperation programme
Funding Schemes
Collaborative projects
Projects can range from small or medium-scale focused research actions (CP)
Large‑scale integrating projects for achieving a defined objective. (Large CP)
Coordination and support actions
Support for activities aimed at coordinating or supporting research activities and policies (networking, exchanges, trans-national access to research infrastructures, studies, conferences, etc.). (CA) and (SSA)
Networks of Excellence

11. FP7 /Cooperation programme (collaborative research)
10 Themes
1. Health
2. Food, agriculture & fisheries and biotechnology
3. Information Society and Communication Technologies -> ICT
4. Nanosciences, nanotechnologies, Materials & new Production technologies -> NMP
5. Energy
6. Environment (including climate change)
7. Transport (including aeronautics)
8. Socio-economic sciences & the humanities
9. Security
10. Space M€
6 100/ April
1 935/ May
9 050/ May
3 475/364 4May1st
2 350/ May
1 890/ May
4 160/ May
623/ May
1 400/ Jun
1 430/ May

12. 4. Nanosciences, Nanotechnologies, Materials and new Production Technologies
Nanosciences and nanotechnologies
Materials
New production
Integration of technologies for industrial applications
Workprogrammes include indicative priorities for future calls!!!

13. Selected topics in Materials and Nanotechnology in FP7
Nanomaterials
NMP
Large CP
Nanostructured polymer-matrix composites
NMP CP
Nanostructured coatings and thin films
NMP
Organic materials for electronics and photonics
NMP
Nanostructured materials with tailored magnetic properties
NMP
Advanced material architectures for energy conversion
NMP
Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering
NMP
Nanostructured catalysts with tailor-made functional surfaces
NMP
Renewable materials for functional packaging applications
NMP
Modelling of microstructural evolution under work conditions and in materials processing

14. Nanomaterials –cont’d
ENERGY CP
Novel nanostructured materials for hydrogen storage
ENERGY
Basic research for materials and processes for Polymer Electrolyte Membrane Fuel Cells (PEMFC)
ENERGY
Basic research on materials and processes for High Temperature Fuel Cells (SOFC & MCFC)
ENERGY
New materials and processes for advanced electrolysers
ENERGY
New materials and processes for advanced multi-fuel processors
AAT
CP, CSA
Aerostructures
Nanoelectronics
ICT
CP, NoE, CSA
Next generation nanoelectronics components and electronics integration
ICT
CP, CSA (CA only)
Nano-scale ICT devices and systems

15. Nanoscience
NMP CP
Nano-scale mechanisms of bio/non-bio interactions
NMP
Self-assembling and self-organisation
NMP
CSA
Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications
NMP
Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory
NMP
CSA (ERANET)
ERANET Plus in nanosciences

16. Technology development
NMP
Large CP
Pilot lines to study, develop and up-scale nanotechnology-based processes from laboratory
NMP
SME-targeted CP
Equipment and methods for nanotechnology
NMP
CSA
Analysis of the ethical, regulatory, social and economic environment of nanomedicine
NMP
Coordination in nanometrology
NMP
Examining capacity building in nanobiotechnology
NMP
Rapid Manufacturing Concepts for Small Series Industrial Production
NMP
Processes and Equipment for High Quality Industrial Production of 3-Dimensional Nanosurfaces
NMP
Production Technologies and equipment for Micro-Manufacturing
NMP
Multifunctional materials for future vehicles

17. Impact assessment and societal issues
NMP
Large CP
Specific, easy-to-use portable devices for measurement and analysis
NMP CP
Risk assessment of engineered nanoparticles on health and the environment
NMP
CSA
Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles
NMP
Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles
NMP
Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products
HEALTH
Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics
SiS CT
Science in Society: Nanoscience and Nanotechnology

18. Nanomedicine
NMP
Large CP
Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topics HEALTH and HEALTH )
HEALTH CP
Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy
HEALTH
Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy
HEALTH
Large CP 2nd call
Development of emerging gene therapy tools and technologies for clinical application
ICT
Large CP, CSA
Personal Health Systems for Monitoring and Point-of-Care diagnostics

19. * 2nd for ICT call will be public May/June 2007
Other Important Topics
ICT
CP, NoE, CSA 2nd call*
Micro/nanosystems
ICT
CP, NoE, CSA 2nd call
Photonic components and subsystems
ICT-2007-C
CP, CSA (CA only)
FET (Future and Emerging Technologies) Open
(Open call for bottom-up activities)
AAT
CP, CSA
Life-cycle [of air vehicles, including increased use of nanotechnologies]
KBBE CP
Nano-devices for quality assurance, food safety and product properties
KBBE
Innovative and safe packaging
KBBE
Converging technologies and their potential for the food area
* 2nd for ICT call will be public May/June 2007

20. 1. S/T quality (in relation to the topics addressed by the call)
FP7 /Collaborative projects Evaluation Criteria
1. S/T quality (in relation to the topics addressed by the call)
2. Implementation
3. Impact
Sound concept, and quality of objectives
Progress beyond the state-of-the-art
Quality and effectiveness of the S/T methodology and work plan
Appropriateness of the management structure and procedures
Quality and relevant experience of the individual participants
Appropriate allocation and justification of committed resources
Contribution to impacts listed in the work programme under relevant topic/activity
Appropriateness of dissemination and/or exploitation of projects results, plans

21. Potential Joint Technology Initiative:
New Nanoelectronics Approaches
Hydrogen and Fuel Cells for Sustainable Energy Future
Aeroanutics and Air Transport
Global Monitoring for Environment and Securitu
Embedded Systems
Innovative Medicines Initiative
Technology Platforms related to Theme 4:
ENIAC: European Nanoelectronics Initiative Advisory Council
NanoMedicine- Nanotechnologies for Medical Applications
Technology Platform on Sustainable Chemistry
Steel
Future Textiles & Clothing
Manufacturing Technologies
The European Construction Technology Platform
Industrial Safety
The European Hydrogen and Fuel Cell Technology Platform
The European Technology Platform on Photovoltaics
Photonics 21: The Photonics Technology Platform
EUMAT: European TP for Advanced Engineering Materials and Technologies
European Aluminum Technology Platform
Updated 250/10/2006 per A. O’Rourke

22. Support to individual teams through Europe-wide competition
FP7/ Ideas
Frontier research
Investigator-driven
Support to individual teams through Europe-wide competition
Governance: European Research Council
Executive Agency

23. FP7/ Ideas Scientific Council
22 high level scientists reflecting the full scope of European research, nominated by Commission
Dr. Claudio BORDIGNON (IT) Professor Manuel CASTELLS (ES) Prof. Dr. Paul J. CRUTZEN (NL) Prof. Mathias DEWATRIPONT (BE) Dr. Daniel ESTEVE (FR) Prof. Pavel EXNER (CZ) Prof. Dr. Hans-Joachim FREUND (DE) Prof. Wendy HALL (UK) Prof. Dr. Carl-Henrik HELDIN (SE) Prof. Dr. Fotis C. KAFATOS (GR) Prof. Dr. Michal KLEIBER (PL) Prof. Norbert KROO (HU) Prof. Maria Teresa V.T. LAGO (PT) Dr. Oscar MARIN PARRA (ES) Prof Robert MAY (UK) Prof. Helga NOWOTNY (AT) Prof. Christiane NÜSSLEIN-VOLHARD (DE) Dr. Leena PELTONEN-PALOTIE (FI) Prof. Alain PEYRAUBE (FR) Dr. Jens R. ROSTRUP-NIELSEN (DK)
Prof. Salvatore SETTIS (IT) Prof. Dr. Rolf M. ZINKERNAGEL (CH)

24. Role of the Scientific Council
FP7 / Ideas
Role of the Scientific Council
Establish overall scientific strategy and preparation of work programmes (incl. calls for proposals, evaluation criteria)
Define scientific management: peer review methodology; selection and accreditation of experts; monitor quality of operations and evaluate programme implementation
Assure communication with the scientific community

25. FP7 / Ideas Work Programme / Launch strategy
Two streams of activity are foreseen:
- Early stage independent investigators (“Starting Grants”)
> 2 < 9 years after PhD
up to 5 years project
~1/3 of the annual budget:
M€ per year (200 grants)
- Established Investigators (“Advanced Grants”)

26. FP7 / IDEAS Starting Grants / Evaluation criteria
The potential of the people and their track record (research excellence of the applicant at the PhD level and subsequently, achievements, publication list)
Excellence of the project:
- Scientific value
- Innovativeness
- Feasilibility of objectives sought
- Methodology proposed
- Project management
- Research environment

27. FP7 / IDEAS Starting Grants / Evaluation criteria
Principal Investigator: Potential to perform world class research
Quality of research output: Has the Principal Investigator published in high quality peer reviewed journals or the equivalent? To what extent are these publications ground-breaking and demonstrative of independent creative thinking and capacity to go significantly beyond the state of the art?
Intellectual capacity and creativity: To what extent does the Principal Investigator's record of research collaborations, project conception, supervision of students and publications demonstrate that he/she isable to confront major research challenges in the field, and to initiate new productive lines of thinking?
2. Quality of the proposed research project
Ground-breaking nature of the research: Does the proposed research address important challenges in the field(s) addressed? Does it have suitably ambitious objectives, which go substantially beyond thecurrent state of the art (e.g. including trans-disciplinary developments and novel or unconventiona approaches)?
Potential impact: Does the research open new and important scientific, technological or scholarly horizons?
Methodology: a) is the outlined scientific approach (including the activities to be undertaken by the individual team members) feasible? (Stage 1) b) is the proposed research methodology (including when pertinent the use of instrumentation, other type of infrastructures etc.) comprehensive and appropriate for to the project? Will it enable the goals of the project convincingly to be achieved within the timescales and resources proposed and the level of risk associated with a challenging research project? (Stage 2)
3. Research Environment
Transition to independence: Will the proposed project enable the Principal Investigator to make or consolidate the transition to independence?
Hosting institution (normally applicant legal entity): Does the institution hosting the project have most of the infrastructure necessary for the research to be carried out? Is it in a position to provide an appropriate intellectual environment and infrastructural support and to assist in achieving the ambitions for the project and the Principal Investigator?
Participation of other legal entities: If it is proposed that other legal entities participate in the
project, in addition to the applicant legal entity, is their participation fully justified by the scientificadded value they bring to the project?

28. FP7 / IDEAS Starting Grants / Evaluation criteria

29. FP7 / Ideas Starting Grants / Peer review panel Social Sciences
SH1 Individuals and organisations: Economics, management, demography, geography, urban and environmental studies.
SH2 Institutions, behaviour, values and beliefs: Anthropology, sociology, political science, law, communication, social studies of science and technology.
SH3 The human mind and its complexity: Cognition, linguistics, psychology and philosophy.
SH4 Cultures and cultural diversity: Literature, visual and performing arts, music and cultural studies.
SH5 The study of the past and of cultural artefacts: Memory, history and archaeology.

30. FP7 / Ideas Starting Grants / Peer review panel Natural Sciences & Engineering
PE1 Mathematical foundations: Pure and applied mathematics, theoretical computer science and mathematical physics.
PE2 Fundamental constituents of matter: High energy, particle, nuclear, plasma, atomic, molecular, gas and optical physics.
PE3 Structures and reactions: Condensed matter (structure, electronic properties, fluids,…), statistical physics, nanosciences, reactions.
PE4 Material sciences and methods: Material sciences, molecular architecture, analytical chemistry, synthesis (both inorganic and organic) and theory, physical and environmental chemistry, method development.
PE5 Information and communication: Informatics and information systems, communication technology, computer science, intelligent systems.
PE6 Engineering sciences: Electronics, product design, process design & control, construction methods, fluid and solid mechanics, energy systems, bio- engineering.
PE7 Universe sciences: Astro-physics/chemistry/biology/geology; solar system; stellar, galactic and extragalactic astronomy; cosmology; space sciences, instrumentation.
PE8 Earth system science: Physical geography, geology, geophysics,
oceanography, climatology, ecology, global change, biogeochemical cycles, natural resources.

31. FP7 / IDEAS Starting Grants / Peer review panel Life Sciences
LS1 Molecular, cellular and developmental biology: Biochemistry, molecular biology, metabolism, cell biology, signal transduction, embryology, structural biology.
LS2 Genetics, genomics, bioinformatics and systems biology: Molecular genetics, cell genetics, genomics, transcriptomics, metabolomics, computational biology, biostatistics, biological modelling.
LS3 Organismic physiology, including infection and immunity: Organogenesis, organ
physiology, endocrinology, ageing, toxicology, parasitology, microbiology, virology, immunology.
LS4 Neurosciences: Neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, systems neuroscience, neuroimaging.
LS5 Evolutionary, population and environmental biology: Evolution, adaptation, population biology, biodiversity, ecotoxicology, marine biology, radiation biology,
environmental risks, environmental medicine.
LS6 Applied medical and health sciences: Clinical medicine, public health, psychiatry, surgery, epidemiology, biomedical engineering, veterinary medicine, pharmacology, medical ethics.
LS7 Applied biology and bioengineering, including agricultural sciences and
biotechnology: Genetic engineering, GMOs, synthetic biology, plant biology,
fisheries, forestry,environmental biotechnology, industrial biotechnology,
biomaterials, biohazards

32. FP7 / People Human potential
OBJECTIVE-> TO MAKE EUROPE MORE ATTRATIVE FOR THE BEST RESEARCHERS
Scope
Human resource development in R&D in Europe
Numerous, well-trained, motivated researchers
Attract students to research careers
Attract researchers to Europe and retain skills and sustainable career development
Appropriate gender balance

33. FP7 / People Activities/ 1st calls for proposals
Initial training of researchers
- Marie Curie Networks
FP7-PEOPLE ITN May-25 Sept 2007
Life-long training and career development
Individual Fellowships (IEF)
FP7-PEOPLE IEF 14 August 2007
- Co-financing of regional/national/international programmes
FP7-PEOPLE COFUND 17 Oct 2007
Industry-academia pathways and partnerships
- Industry-Academia Scheme
FP7-PEOPLE IAPP 31 May 2007

34. FP7 / People Activities/1st call for proposals
International dimension
- Outgoing International Fellowships
FP7-PEOPLE IOF 14 August 2007
- Incoming International Fellowships
FP7-PEOPLE IIF 14 August 2007
- Reintegration grants
FP7-PEOPLE IRG
Continuous submission with "cut-off dates" for proposals received until 25 April and 17 Oct 2007
Specific actions
- Excellence awards
FP7-PEOPLE AWARDS 29 March 2007
- Researchers' night
FP7-PEOPLE NIGHT 3 April 2007

35. FP7 / Capacities Research Capacity
OBJECTIVE-> TO UNDERPIN THE NEEDS TO PERFORM RESEARCH
Research Infrastructures INFRA Pan-European R I for Nano-structures M€
Research benefit of SMEs FP7-SME M€
Regions of Knowledge 126 M€
Research Potential M€
Science in Society M€
International Cooperation 180 M€
Coherent Development of Policies 70 M€

36. Important definitions
FP7/Rules of participation and the Model Grant Agreement
Important definitions
Public body:
any legal entity established as such by national law, and international organisations.
Research organisation
a legal entity established as a non-for-profit organisation which carries out research or technological development as one of its main objectives.
Higher and secondary education establishments
Includes universities, schools for applied sciences and similar.
SMEs
Micro, small and medium-sized enterprises within the meaning of Recommendation 2003/361/EC in the version of 6 May 2003 (OJ L 124, , p. 36).
International cooperation partner countries:
FP6 INCO countries – three categories according to income per capita (low-income, lower-middle-income, or upper-middle-income); will be identified as such in the work programmes.

37. Conditions for participation
Minimum condition, general rule, at least 3 independent participants from 3 different MS or Ac
Additional conditions can be established by the SP or WP (number or type of participant, place of establishment)
Specific conditions may also apply for:
Frontier research actions, at least 1 legal entity established in a MS or Ac
Collaborative projects addressing the participation of International Cooperation Partner Countries (ICPC) minimum is 4 participants, 2 of which from MS or Ac and another 2 from ICPC countries unless otherwise foreseen in the WP

38. Upper funding limits (1)
Reimbursed will be according to the type of action and/or activity
Research and technological development activities: up to 50% of eligible costs, or up to 75% for:
Non profit public bodies
secondary and higher education establishments
research organisations
SMEs
Security related research, for highly reliable capabilities with impact on security of European citizens and targeted to a limited number of public users
Demonstration activities: up to 50%
Other activities including management: up to 100%

39. Upper funding limits (2)
Actions that will be reimbursed up to 100%:
Frontier research
Coordination and support actions
Training and career development of researchers

41. Reimbursement of eligible costs
Most funding schemes, particularly at beginning of FP7 will use reimbursement of eligible costs
Eligible
actual (average personnel costs may be used if do not differ significantly from actual)
incurred during duration of project
in accordance with the beneficiary usual accounting and management principles
recorded in the accounts of beneficiary
used for the sole purpose of achieving the objectives of the project
Non-eligible (identifiable indirect taxes including VAT…)

42. Indirect Cost
Participants may charge eligible direct and indirect costs
Reimbursement of indirect costs:
For all:
either actual overhead, or simplified method, or
flat rate of 20% of direct costs
For Non profit Public Bodies, Secondary and Higher Education establishments, Research Organisations, and SMEs unable to identify real indirect costs, may apply for a flat rate of 60% for funding schemes with Research, Technological Development & Demonstration
For Coordination and Support Actions limit of
7% of direct costs

43. Simplified method
A participant may use a simplified method to calculate its indirect costs if this is in accordance with its usual management and accounting principles
Why this new approach?
The Council wished to introduce a way to facilitate the transition from the Additional Cost model (abolished) towards the declaration of actual indirect costs
EP added the 60% flat rate for indirect costs for specific entities, being unable to identify their indirect costs

44. Certification on the methodology
It aims at certifying the methodology of calculating (average) personnel costs and overhead rates
Waives the obligation of certificates for interim payments
Simplified certificate for final payments
Valid throughout FP7, on a voluntary basis, must be accepted by the EC
Particularly aimed at legal entities with multiple participation

45. Certification on financial statements
Under FP7 we do not talk anymore about audit certificates but about certificate on financial statements (CFS)
Certificate on financial statements:
Mandatory when requested funding reaches 375,000 Euro per beneficiary (except for project of 2 years or less: CFS submitted at the end)
If above the threshold, mandatory for every beneficiary, except if a certification on the methodology is provided

46. Risk avoidance mechanism (1)
Participant Guarantee Fund (“the Fund”):
All beneficiaires contribute to the Fund to insure against losses of a defaulting participant
The contribution shall not exceed 5% of the EC financial contribution due to each participant
Financial interests generated by the Fund will serve to cover financial risk
In principle this amount will be reimbursed at the end of the action

47. Terminology
Sources: Financial Regulation/Implementing Rules, FP7 and Rules for Participation
“Contract” becomes “Grant Agreement”
“Contractor” becomes “Beneficiary”
“Instruments” become “Funding Schemes”
“Audit certificate” becomes “Certificate on Financial Statement”
The results of the project (knowledge in FP6) becomes “Foreground”
Pre-existing know-how becomes “Background”

48. Grant agreement
The Commission is about to establish, in close cooperation with Member States, 3 model grant agreements:
General model grant agreement (including specific provisions for SMEs, Infrastructures and ERA-NET+)
Specific model grant agreement for ERC actions
Specific model grant agreement for Marie-Curie actions

49. Similarities with FP6 Signature by coordinator & Commission
Accession of beneficiaries via “Form A”
Later accession of beneficiaries via “Form B”
Entry into force upon signature by coordinator & Commission

50. Payment modalities
One pre-financing (upon entry into force) for the whole duration of the action
Interim payments based on financial statements (EC contribution= amounts justified & accepted * funding rate)
Retention (10%)
Final payment

51. Consortium agreement
Unless exempted by the call for proposals, participants will have to draw up a “consortium agreement”, to govern the following:
(a) The internal organisation of the consortium
(b) The distribution of the Community financial contribution
(c) Additional rules on dissemination and use including intellectual property rights arrangements, as appropriate
(d) The settlement of internal disputes.

52. Who evaluates proposals How to become evaluator for FP7 Cooperation
The Commission invites individuals to apply as prospective independent experts in order to be included in its database of experts for the Seventh Framework Programme

53. Who evaluates proposals How to become evaluator for FP7 Ideas
The Commission has invited the Member States to submit candidates as independent experts in order to be included in its specific database as panel Chairs and panel members and a pool of referees.
Panel Chairs are expected to be internationally recognised, senior scientists in their fields.
Panel members are expected to be senior scientists in their fields, actively pursuing research at the front line.

54. Further information Information research programmes projects: http://cordis.europa.eu/fp7
EU research:
RTD info magazine:

55. Single Helpdesk: Research Enquiries Service